CRISPR Therapeutics AG (CRSP)
50.50
+0.62
(+1.24%)
USD |
NASDAQ |
Oct 21, 16:00
49.85
-0.65
(-1.29%)
After-Hours: 04:08
CRISPR Therapeutics Net Income (Annual) : -581.60M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -581.60M |
| December 31, 2024 | -366.25M |
| December 31, 2023 | -153.61M |
| December 31, 2022 | -650.18M |
| December 31, 2021 | 377.66M |
| December 31, 2020 | -348.86M |
| Date | Value |
|---|---|
| December 31, 2019 | 66.86M |
| December 31, 2018 | -164.98M |
| December 31, 2017 | -68.36M |
| December 31, 2016 | -23.20M |
| December 31, 2015 | -25.83M |
| December 31, 2014 | -6.80M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.953B |
| Basilea Pharmaceutica AG | 48.45M |
| Santhera Pharmaceuticals Holding AG | -59.29M |
| BeOne Medicines Ltd. | 287.69M |
| Intellia Therapeutics, Inc. | -412.69M |